+Search query
-Structure paper
Title | Oxetane promise delivered: discovery of long acting IDO1 inhibitors suitable for Q3W oral or parenteral dosing |
---|---|
Journal, issue, pages | To Be Published |
Publish date | Aug 9, 2021 (structure data deposition date) |
Authors | Li, D. / Sloman, D. / Achab, A. / Zhou, H. / McGowan, M. / White, C. / Gibeau, C. / Zhang, H. / Pu, Q. / Bharathan, I. ...Li, D. / Sloman, D. / Achab, A. / Zhou, H. / McGowan, M. / White, C. / Gibeau, C. / Zhang, H. / Pu, Q. / Bharathan, I. / Hopkins, B. / Liu, K. / Ferguson, H. / Fradera, X. / Lesburg, C.A. / Martinot, T.A. / Qi, J. / Song, Z.J. / Yin, J. / Song, L. / Wan, B. / D'Addio, S. / Solban, N. / Miller, R. / Zamlynny, B. / Bass, A. / Freeland, E. / Ykoruk, B. / Hilliard, C. / Ferraro, J. / Zhai, J. / Knemayer, I. / Otte, K. / Vincent, S. / Sciammetta, N. / Pasternak, A. / Bennett, D.J. / Han, Y. |
External links | Search PubMed |
Methods | X-ray diffraction |
Resolution | 2.76 Å |
Structure data | PDB-7rrd: |
Chemicals | ChemComp-6IZ: ChemComp-HOH: |
Source |
|
Keywords | OXIDOREDUCTASE / INDOLEAMINE DIOXYGENASE / HEME / INHIBITOR |